CHMD low risk below 15: Potential 50 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : CHMD low risk below 15: Potential 50

CHMD 0.00

Jun 29 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dan Turner who wrote (190)	1/28/1998 7:31:00 PM
From: david wills	Read Replies (2) of 241

hi Dan, no i hadn't seen the news.thanks for posting.down again today,hope that somebody gets interested in this stock. David Hambrecht & Quist issued Company Report On October 23, 1997 Hambrecht & Quist analyst Dirk Godsey issued a 3 page Company Report on CHRONIMED INC. Report highlights: " The fiscal 1998 EPS estimate was increased to $0.53 to account for the strong operating results of the first quarter. The BUY rating was maintained based on expectations of solid growth in revenue, earnings and market position for the company. The better-than-expected fiscal first quarter 1998 EPS was driven by continued outstanding growth in the self injectibles and StatScript businesses, as well as solid growth in Supreme reagent strips. " Dirk Godsey is ranked 1 out of 9 when predicting changes in stock prices for Chronimed, Inc. Dirk Godsey is ranked 3 out of 9 when forecasting EPS for Chronimed, Inc. Dirk Godsey has had an average historical error of $-0.05 when forecasting EPS, and generated an average excess return of -12.00% when making stock recommendations for this company. h&q issued another buy reccomandation on 1/22 but i wasn't able access it to post.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next